Xiamen Amoytop Biotech Co Ltd Cash Flow-to-Debt Ratio
Xiamen Amoytop Biotech Co Ltd cash flow-to-debt ratio. Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow-to-Debt Ratio of 0.74x as of September 2023, meaning its operating cash flow of CN¥332.29 Million could theoretically repay 1% of its total liabilities (CN¥447.44 Million) in one year. Check Xiamen Amoytop Biotech Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xiamen Amoytop Biotech Co Ltd (2016–2024)
Cash flow-to-debt ratio of Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. Historical debt coverage capacity for Xiamen Amoytop Biotech Co Ltd across 9 annual periods. Check Xiamen Amoytop Biotech Co Ltd (688278) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Xiamen Amoytop Biotech Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
Xiamen Amoytop Biotech Co Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Xiamen Amoytop Biotech Co Ltd. For the full cash flow conversion analysis, see how efficiently does Xiamen Amoytop Biotech Co Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.87x | CN¥430.63 Million | CN¥497.10 Million | ▼ -18.9% |
| 2023 | 1.07x | CN¥512.10 Million | CN¥479.69 Million | ▲ +6.1% |
| 2022 | 1.01x | CN¥363.16 Million | CN¥360.96 Million | ▲ +12.7% |
| 2021 | 0.89x | CN¥234.78 Million | CN¥262.91 Million | ▲ +85.5% |
| 2020 | 0.48x | CN¥92.61 Million | CN¥192.33 Million | ▼ -11.6% |
| 2019 | 0.54x | CN¥123.30 Million | CN¥226.27 Million | ▲ +27.5% |
| 2018 | 0.43x | CN¥89.15 Million | CN¥208.51 Million | ▲ +676.8% |
| 2017 | -0.07x | CN¥-11.41 Million | CN¥153.86 Million | ▼ -128.7% |
| 2016 | 0.26x | CN¥42.43 Million | CN¥164.49 Million | — |